arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

PMV Pharmaceuticals, Inc.

PMVP Health Care Biotechnology: Pharmaceutical Preparations
$1.27
▼ -6.6% Today
as of Oct 23, 16:51 ET
Last 30 days -13.01% Sep 14 → Oct 23
$1.16 $1.33 $1.50 $1.67 $1.84 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.30
High
$1.33
Low
$1.25
Volume
$170,991
Avg Vol
$488,239
Mkt Cap
$132M
P/E (TTM)
—
Beta
—
52w High
$1.91
52w Low
$1.02
Div Yield
—
Shares Out
$53M

Recent Press Releases & News last 60 days · 9 items

Oct 12 · 14:55 Zacks
PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know
Oct 5 · 12:00 PR GlobeNewswire
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
Sep 16 · 13:55 Zacks
Should You Buy PMV Pharmaceuticals, Inc. (PMVP) After Golden Cross?
▸ Show all 9 press releases & news Free account →

PMVP earnings at a glance

The options market is pricing a move of about ±130.9% after the report, a range of roughly -$0.39 to $2.93 from today's $1.27. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±1.1% on average; after the most recent report on May 12, 2026 it moved +2.2%. That means options currently expect more movement than PMVP has typically delivered. PMVP beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 11%. The share price of $1.27 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.02
$1.91
28% of range
Avg surprise (last 4)
+5.0%
Avg reaction (last 2)
+1.0%
50% positive
Latest IV / EM
1108%
EM ±130.9% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.42$-0.32$-0.22$-0.12$-0.02 Actual $-0.42Actual $-0.38Actual $-0.34Actual $-0.30Actual $-0.02Actual $-0.37Actual $-0.34Est $-0.37Actual $-0.41Est $-0.39Actual $-0.40Est $-0.40Actual $-0.34Est $-0.41Actual $-0.34 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-21M$-20M$-20M$-19M$-18M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.34 — — — — financials
Tue May 12, 2026Mar/2026 $-0.34 $-0.41 +17.1% 0.0% +2.2% earnings
Wed Nov 12, 2025Sep/2025 $-0.40 $-0.40 0.0% — — earnings
Thu Aug 7, 2025Jun/2025 $-0.41 $-0.39 -5.1% — — earnings
Fri May 9, 2025Mar/2025 $-0.34 $-0.37 +8.1% — -0.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.37 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.02 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.30 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.34 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.38 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.42 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-19M$-19M—$-23M$-23M$-22M—$-22M
Net income$-18M$-18M—$-21M$-21M$-17M—$-19M
EPS (diluted)$-0.34$-0.34—$-0.40$-0.41$-0.34—$-0.37

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$12M$39M$38M$36M$44M$51M$41M$49M
Inventory————————
Total current assets$81M$96M$115M$132M$145M$163M$176M$190M
Total assets$82M$97M$117M$134M$153M$171M$191M$223M
Long-term debt————————
Total liabilities$11M$9M$12M$13M$12M$11M$15M$26M
Total equity$72M$88M$105M$121M$141M$160M$176M$198M

Implied volatility — last 90 days

582%1743%2903%4063%5224% Jun 07 — IV 1773% · EM ±245.5%Jun 08 — IV 1910% · EM ±252.3%Jun 09 — IV 2128% · EM ±266.7%Jun 10 — IV 1557% · EM ±184.0%Jun 11 — IV 2408% · EM ±266.1%Jun 12 — IV 2466% · EM ±252.3%Jun 15 — IV 2087% · EM ±150.9%Jun 16 — IV 2472% · EM ±146.0%Jun 17 — IV 5224% · EM ±218.2%Jun 19 — IV 1121% · EM ±247.8%Jun 22 — IV 672% · EM ±140.4%Jul 15 — IV 2600% · EM ±153.6%Jul 24 — IV 1368% · EM ±302.4%Jul 27 — IV 1684% · EM ±351.7%Jul 28 — IV 1444% · EM ±295.5%Jul 29 — IV 1610% · EM ±322.4%Jul 30 — IV 1604% · EM ±314.2%Jul 31 — IV 1624% · EM ±310.8%Aug 03 — IV 1738% · EM ±308.0%Aug 04 — IV 2085% · EM ±359.0%Aug 19 — IV 3373% · EM ±199.2%Aug 24 — IV 862% · EM ±180.1%Aug 27 — IV 1276% · EM ±250.0%Sep 01 — IV 1066% · EM ±183.6%Sep 02 — IV 1592% · EM ±265.9%Sep 03 — IV 1271% · EM ±205.6%Sep 21 — IV 750% · EM ±156.5%Sep 22 — IV 664% · EM ±135.8%Sep 23 — IV 729% · EM ±146.0%Oct 01 — IV 583% · EM ±94.3%Oct 06 — IV 682% · EM ±90.1%Oct 08 — IV 1108% · EM ±130.9%

Sector peers

SPRB
Spruce Biosciences, Inc.
$129M $45.15+5.7%
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$123M $4.05-5.5%
AARD
Aardvark Therapeutics, Inc.
$115M $1.39-68.5%
LIXT
Lixte Biotechnology Holdings, Inc.
$115M $7.21+75.8%
GNLX
Genelux Corporation
$114M $2.00-3.4%
ASRT
Assertio Holdings, Inc.
$151M $23.50

PMVP earnings FAQ

What is PMVP's expected move for earnings?

Options currently price a move of about ±130.9%, or $1.66 per share either way from $1.27.

How does PMVP stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.1%, up 1 times and down 1 times.

What is PMVP's implied volatility?

PMVP's at-the-money implied volatility is about 11% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in